Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic Peptide

SIMPLE SUMMARY: Breast cancer is the most commonly diagnosed cancer and the second leading cause of cancer deaths among women globally. Due to its biological heterogeneity, breast cancer treatment and prognosis are highly variable among patients. In particular, the triple-negative subtype (TNBC) has...

Descripción completa

Detalles Bibliográficos
Autores principales: Jannoo, Riaz, Walker, William, Kanamarlapudi, Venkateswarlu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216279/
https://www.ncbi.nlm.nih.gov/pubmed/37345109
http://dx.doi.org/10.3390/cancers15102772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216279/
https://www.ncbi.nlm.nih.gov/pubmed/37345109
http://dx.doi.org/10.3390/cancers15102772

Ejemplares similares